Morbidity-mortality evaluation of the If inhibitor ivabradine in patients with coronary disease and left ventricular dysfunction
Forgotten password ?
  • general information
  • healthcare professionals
  • press office
  • Results
  • Events
  • About Heart Rate
  • About Ivabradine
  • About If current
  • FAQ
  • Expert Opinions
  • Publications

BEAUTIFUL
TRIAL
steto
  • Results in angina patients
  • Principal Results
  • Fast Facts
  • Rationale
  • Objectives and Design
  • Baseline characteristics
  • Substudies
  • Investigators
  • Slide set
EVENTS
steto
  • Hotline ESC '08
ABOUT
HEART RATE
steto
  • A key determinant of myocardial ischemia
  • A predictor of morbidity and mortality
ABOUT IVABRADINE
steto
  • Pure heart rate reduction with ivabradine
  • Clinical evidence with ivabradine
  • Further development in the cardiovascular disease spectrum
ABOUT If CURRENT
steto
QUESTIONS AND ANSWERS
steto
EXPERT OPINIONS
steto
PUBLICATIONS
steto
Home Healthcare Professionals BEAUTIFUL Study

Substudies of the BEAUTIFUL Study


Two substudies have been scheduled:


top

Contact Site map Search engine
This site is published and updated by the BEAUTIFUL study investigators
Scientific advisor: Prof M. Bertrand